Glycemic excursion minimization
1 paper2 findings
- 1 lab
- Human trial1
Outcomes
2HbA1c
downin humans1
1 study
HbA1c
downin humans1
Glycemic excursion minimization decreases HbA1c in humans.
“The GEM intervention showed improvement in glycemic outcomes relative to RC in glucose variability as measured by CGM SD and CV, and A1c”
Human trialprediabetes3-months
ADA Scientific Sessions 2025 abstract13 Jun 2025
Glucose variability
downin humans1
1 study
Glucose variability
downin humans1
Glycemic excursion minimization decreases glucose variability in humans.
“GEM plus CGM improved glycemic outcomes in a prediabetes sample.”
Human trialprediabetes3-months
ADA Scientific Sessions 2025 abstract13 Jun 2025
Latest
ADA Scientific Sessions 2025 Abstract
Libre 2 CGM plus Glycemic Excursion Minimization (GEM) in the Treatment of Prediabetes (the IMPEDE Study)
Randomised trial in peoplePrediabetes